This was about justice for Danny. We didn't win anything tonight — we basically lost another life. But we did win justice.' - ...
Billy Leon Kearse, convicted for the 1991 killing of Fort Pierce Police Officer Danny Parrish during a traffic stop, was ...
NewcelX Ltd. ("NewcelX") (Nasdaq: NCEL), a clinical-stage company advancing stem-cell-derived therapies for Type 1 Diabetes, today announced a collaborative research agreement with Eledon ...
A collaborative integration model to enable practical, scalable cell and gene therapy delivery. SINGAPORE, March 5, 2026 ...
Collaboration Integrates Stem-Cell-Derived Islets with Targeted Immune Modulation ZURICH, Switzerland, March 9, 2026 /PRNewswire/ -- NewcelX Ltd. ("NewcelX") (Nasdaq: ...
UCB secured worldwide exclusive rights to develop, manufacture, and commercialize ATG-201, including access to Antengene’s enabling manufacturing technology for this bispecific T-cell engager modality ...
Europe’s battery startups keep hitting the same wall: expensive power, slower scaling, heavy capex, and relentless price competition from Asian giants backed by industrial policy. Without competitive ...
Company is well positioned following positive FDA Type B meeting outcome, fully enrolled Phase 2 trial for its lead clinical program, and recent $5 million public offering, as commercial operation ...
Oklahoma has carried out its first execution of the year on a man convicted of killing two men in a drive-by shooting.
FuelCell Energy, Inc. (NASDAQ: FCEL) today reported financial results for its first quarter ended January 31, 2026.
In today’s ACT Brief, we examine how site-level data capture is becoming central to trial execution, how Merck and Mayo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results